We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0EMN market cap is 189.17M. The company's latest EPS is SEK -0.4302 and P/E is -6.23.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 36.17M | 28.15M | 29.18M | 37.08M | 31.05M |
| Operating Income | 7.44M | -7.75M | -11.82M | -8.36M | -30.34M |
| Net Income | 6.91M | -8.04M | -12.24M | -8.58M | -30.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 85.84M | 112.7M | 101.8M | 96.08M | 65.84M |
| Total Liabilities | 22.49M | 17.49M | 18.85M | 21.71M | 21.81M |
| Total Equity | 63.35M | 95.2M | 82.95M | 74.36M | 44.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 9.47M | 1.26M | -695k | -636k | -9.46M |
| Investing | -3.6M | -2.01M | -2.55M | -1.9M | -3.55M |
| Financing | -4.25M | 34.49M | -3.79M | -6.02M | -6.63M |
| Market Cap | 189.17M |
| Price to Earnings Ratio | -6.23 |
| Price to Sales Ratio | 6.09 |
| Price to Cash Ratio | 14.68 |
| Price to Book Ratio | 4.3 |
| Dividend Yield | - |
| Shares Outstanding | 70.59M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 2.68 |
| 52 Week Low | 2.68 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Glycorex Transplantation Ab (publ) |
| Address |
solvegatan 41 lund 223 70 |
| Website | https://www.glycorex.se |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
